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the alveolar mucosa accompanying with
sialidosis type 2 in Japanese infantMiyoko Hidaka a,*, Akihiro Yamashita a, Kouzou Sakamoto a,
Ken-ichi Mukaisho b, Takanori Hattori b, Gaku Yamamoto aa Department of Oral and Maxillofacial Surgery, Shiga University of Medical Science, Seta-tsukinowa-cho,
Otsu, Shiga 520-2192, Japan
b Department of Pathology, Shiga University of Medical Science, Seta-tsukinowa-cho, Otsu, Shiga
520-2192, JapanReceived 9 March 2005; accepted 9 March 2005Summary Benign fibrous histiocytoma with sialidosis which is a rare metabolic dis-
order resulting from the deficiency of a lysosomal enzyme, and a-neuraminidase, as
one of lysosomal storage diseases. The patient; male infant (2 years and 8 months),
with infantile form of sialidosis type 2, shows extensive gingival enlargement and
gingival tumor with a painless mass (4 · 2 · 2 cm), which grew gradually on the gin-
giva of left maxillary deciduous molar region. A tumorectomy was performed to
improve the mastication. The surgical specimen had many histiocytes positive for
CD68 with cytoplasmic vacuoles, which is a specific feature in the patient of glyco-
protein degradation disorder. These histiocytes were also positive for lysozyme. The
gingival tumor was diagnosed as benign fibrous histiocytoma. The present report is
discussed glycoprotein degradation disorder accompanying with gingival hyperpla-
sia.c 2005 Elsevier Ltd. All rights reserved.
KEYWORDS
Gingival histiocytoma;
Sialidosis;
Cytoplasmic vacuole;
Immunohistochemistry;
Electronmicroscopy1
d
2
d741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights rese
oi:10.1016/j.ooe.2005.03.003
* Corresponding author. Tel.: +81 77 548 2352; fax: +81 77 548
347.
E-mail address: mhidaka@belle.shiaga-med.ac.jp (M. Hi-
aka).Introduction
Sialidosis is classified as one of lysosomal storage
diseases, and it is extremely rare glycoprotein deg-
radation disorder (mucolipidosis I) occurring for
deficiency of the a-neuraminidase; N-acetyl-
neuramine acid hydrolase (E.C.3.2.1.18) activity.rved.
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a complex with a 32-KD glycoprotein in lysosomal
body. The former protein was found to have a dual
function: it is required for the aggregation of
monomeric 64-KD b-galactosidase into high molec-
ular weight (600–700KD) multimers and it is an
essential subunit of neuraminidase together with
a 76-KD polypeptide.1
Defects in neuraminidase activity show clinical
phenotypes.2–8 It has been reported that the defi-
ciency of the primary neuraminidase activity as
sialidosis and sialidosis was divided into two
distinct types: the type 1—a group with normal
physical appearance and body proportions, cher-
ry-red spots, myoclonus; and the type 2—a dysmor-
phic group with short stature and bony
abnormalities.9 It is further divided the type 2 dis-
ease into infantile and juvenile sialidosis. Later,
Young et al.10 added yet another category, desig-
nated congenital sialidosis, to the type 2 subgroup.
The paper deals with a case of the gingival be-
nign fibrous histiocytoma of the patient diagnosed
as an infantile form of sialidosis type 2, and also
discussed with cell biological features in lysosomal
storage disease.Figure 1 (A) Full face showing typical facies of siali-
dosis. (coarse facial feature, front part protrusion,
swelling of eyelid, saddle nose and long philtrum). (B)
The tumor measuring 4 · 2 · 2 cm is detected in a left
side maxilla deciduous at preoperation.Case report
A male patient (2 years and 8 months) complaining
of swollen gums and a painless mass on the gingiva
was referred to our hospital. In familial history, his
mother is a mentally deficient and his father is her
uncle. He had previously been diagnosed as sialido-
sis by the Laboratory evidence of deficiency of the
glycoprotein a-neuraminidase activity and normal
b-galactosidase activity in the peripheral leuco-
cytes. The observation of general global develop-
mental delay and facial specific features
confirmed the diagnosis as infantile form of sialido-
sis type 2.
Extraoral examination showed obvious develop-
mental delay; (1) arms and legs were edematous,
(2) typical facies seen in sialidosis type 2 were
present: coarse facial feature, front part protru-
sion, swelling of eyelid, saddle nose and long phil-
trum (Fig. 1A).
Intraoral examination revealed massive gingival
hyperplasia, a painless mass in the gingiva in left
maxillary deciduous molar region and erupted
lower anterior teeth. It had grown gradually and
the mass showed 4 · 2 · 2 cm in size (Fig. 1B). Upon
palpation, the gingival tissues were flabby and
slightly elastic. The tongue was thick but relatively
normal in appearance and lower 4 primary incisors
had partially erupted.The patient could not close the mouth com-
pletely and he had a disturbance of food intake.
A tumorectomy was performed to improve the
mastication. The healing of wounded area was
good and the feeding condition was improved. In
postoperative 4 months he showed aggravation of
general condition and a recurrence of a tumor
mass. Afterwards the patient died of sudden
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compression by pleural effusion, pulmonary edema
and ascites.Pathological findings
The gingival tumor tissue revealed that covered
epithelium erosion, and it showed macrophages
and fibrous histiocytic cell infiltration in connectiveFigure 2 Histological findings in the gingivectomy specimen
CD34. (A) It showed many histiocytes and fibrous histionic p
multinucleated giant cell. (B, C) Many histiocytes were positi
basal cell layer of gingiva were positive for Ki67. However, Ki6
were no histiocytes positive for CD45 (E) and CD34 (F).tissue. Multinucleated giant cells of touton type
laid scattered in connective tissue (Fig. 2A). Many
histiocytes were positive for CD68 (KP1, 1:100,
DAKO, Glostrup, Denmark), and had cytoplasmic
vacuoles in these histiocytes (Fig. 2B). Also these
histiocytes were positive for lysozyme (Lyso-
zyme, 1:100, DakoCytomation, California, USA).
Lysozyme was present chiefly in granular intrecyto-
plasmic of histiocytes (Fig. 2C). Staining nuclei of
tumor cells were a few for Ki67 (MIB-1, 1:100,
DAKO) (Fig. 2D) and cells were without marked. (A) HE, (B) CD68, (C) Lysozyme, (D) Ki67, (E) CD45, (F)
roliferation. Inset: Higher magnification of touton type
ve for CD68 (B) and lysozyme (C). (D) Several cells in the
7 positive cells were quite rare in this tumor. (E, F) There
256 M. Hidaka et al.atypia. On the other hand, the tumor cells were
negative for CD34 (NU-4A1, 1:100, Nichirei, Tokyo,
Japan) (Fig. 2E), CD31 (JC/70A, 1:100, DAKO), S-
100 (S-100, 1:100, Nichirei), a-SMA (1A4, 1:100,
Dako corporation, CA, USA), and HMB-45 (HMB45,
1:100, Dako corporation). So it was diagnosed as
benign fibrous histiocytoma. Many lymphocytes
were positive for CD45 (4KB5, 1:100, DAKO)
and most of them had cytoplasmic vacuoles
(Fig. 2F).Electron microscopic finding
We used small pieces of paraffin embedding tumor
tissue after deparaffinigation. They were fixed with
2.5% glutaraldehyde in phosphate buffered saline
(PBS) and postfixed with 2% osmium tetroxide in
PBS, and the specimens were embedded in Epon
following dehydration. Ultrathin sections stained
with 2% uranyl acetate in methanol and lead sul-
fate, and examined under a Hitachi H-700 electron
microscopy (model H-700 electron microscope,
Hitachi, Japan). Electron microscopic features re-
vealed many cytoplasmic vacuoles in histiocytes
(Fig. 3A) and lymphocytes (Fig. 3B).Figure 3 Transmission electron microscope image. (A) TEM
in the histiocytes (A), and in the lymphocytes (B).Discussion
Sialidosis is belong to lysosomal storage diseases
for deficiency of a-neuraminidase activity in lyso-
some. Lysosomal storage diseases are classified
into glycogenosis, mucopolysaccharidoses, lipido-
ses, glycoprotein degradation disorders (mucolipi-
dosis) and others according to the stored
substrates by stromal modality or a kind of a
deficient enzyme. Disorders as sialidosis, I-cell dis-
ease, and aspartylglycosaminuria are included in
this mucolipidosis.11 The normal turnover of glyco-
proteins that originate from cytoplasm, cell sur-
face and extracellular matrix, occurs in
lysosomes.12 The deficiency of such enzymes
responsible for this lysosomal turnover of glycopro-
teins causes incomplete degradation of N-glycosid-
ically linked oligosaccharides, and results in
accumulations of these oligosaccharides in the
lysosomes.13 Cytoplasmic vacuoles are caused by
the swollen lysosomes. In glycoprotein dysbolism
patient vacuolated lymphocytes in peripheral
blood are found with high frequency.9 The cyto-
plasmic vacuole is also detected in cells of the skin,
liver and other organs. It is indispensable to do a
tissue biopsy for a child of congenital metabolic· 6000, (B) TEM · 4000. Cytoplasmic vacuoles were seen
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Mallet et al.14 reported that gingival biopsy is easily
performed, is non-iatrogenic, leaves nor scar, and
could be properly used to help diagnose metabolic
diseases in children. Taylor and Shuff15 reported
that the identification of the oral abnormalities
make an important contribution to the diagnosis
of the fatal condition. They appealed for magni-
tude of a gingival biopsy together. In the present
case, we could also detect histiocytes and lympho-
cytes with cytoplasmic vacuolar degenerations,
which is specific feature of glycoprotein degrada-
tion disorder, from intraoral tissue. In the present
case, many histiocytes positive for CD68 and many
lymphocytes positive for CD45 have cytoplasmic
vacuoles. These histiocytic cells showed positive
reaction for lysozyme. Lysozyme (molecular weight
14,000 Da) is a bacteriolytic enzyme and has been
used as immunohistochemical markers for histio-
cytic cells and to test and prove the histiocytic ori-
gin of tumors, such as benign and malignant fibrous
histiocytomas.16 Moreover lysozyme is not
detected in the cytoplasm of neoplastic cell in
non-fibrohistiocytic tumors.17 In the present case,
histiocytic cells were without marked atypia and
Ki67 positive cells are quite rare. So, the tumor
was diagnosed as benign fibrous histiocytoma.
For I-cell disease, massive gingival hyperplasia is
a major expression.18,15,19–23 There are several re-
ports described those gingival overgrowth or hyper-
plasia in other glycoprotein degradation
disorders.24,14,25,26 There is only one report about
gingival hyperplasia of patient presenting sialido-
sis.27 Table 1 showed the list of the description of
gingival hyperplasia in glycoprotein degradation
disorder. Nishimura et al.28 demonstrated that
mice accepting deficiency of a cathepsin-L gene,Table 1 Gingival hyperplasia in glycoprotein storage
diseases degradation
Diseases Author’s name
I-cell disease Galili et al.18
I-cell disease Szigeti et al.20
I-cell disease Patel and Ambani21
I-cell disease Whelan et al.22
Infantile sialidosis type 2 Oohira et al.27
Smith–Lemli–Opitz
syndrome
Parnes et al.24
Aspartylglycosaminuria Bonnaure-Mallet et al.14
I-cell disease Sabbia et al.23
I-cell disease Taylor and Shuff15
Nephrosialidosis Tylki-Szymanska25
Aspartylglycosaminuria Arvio et al.26
I-cell disease Lee and O’Donnell19which is lysosomal proteolytic enzymes, show gin-
gival enlargement. Active block of the cathepsin-
L caused gingival enlargement to be found in I-cell
disease. Complete loss of cathepsin-L function
results in the development of gingival overgrowth.
Taken together, there could be correlation with
resisting glycoprotein degradation disorder and gin-
gival hyperplasia. It is suggested that lowered
activity of lysosomal enzymes is responsible for
gingival hyperplasia as seen in the present case,
and that insufficient protein digestion results in
the excess accumulation of proteins in intercellular
spaces.
The present report is the first description of a
patient with sialidosis who had benign fibrous histi-
ocytoma of the gingiva. This rare case report may
signify a pathogenic mechanism of gingival
overgrowth potentially related to the lysosomal
enzymes, glycoprotein a-neuraminidase.Acknowledgments
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